Illumina
Presence
Illumina is one of the...
Illumina is a company listed under the stock ticker ILMN (US).
Illumina has 3 subsidiaries including Grail, Illumina Ventures and Pacific Biosciences.
They are in:
- Biotechnology50%
- Medical Equipment25%
- Other25%
Executives
View the org chart displaying its 85 main executives
Most searched biographies at Illumina
- Jacob Thaysen, Chief Executive Officer and Director
- Frances Arnold, Director
- Phil Schiller, Director
Popular executive movements at Illumina
- Joydeep Goswami, Chief Financial Officer, Chief Strategy and Corporate Development Officer, will leave the company on Jun. 30, 2024 (posted on April 12 2024).
- Ankur Dhingra has joined the company as Chief Financial Officer (posted on April 12 2024).
- Bas Verhoef, who was Head of Region Europe, is promoted to Interim Chief Commercial Officer (posted on January 7 2024).
Click here to view some more movements at Illumina
Create your alert
to follow the executive moves at Illumina.
Medical Equipment
Illumina has 986 competitors including Philips (Netherlands), Medtronic (Ireland) and Thermo Fisher Scientific (United States (USA)).
Popular M&A news in Medical Equipment
- Medigus will change its company name to Xylo Technologies on Apr 12, 2024. (posted on April 12 2024).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (posted on April 6 2024).
- Carlsmed has just announced a $52 Million fundraising (posted on March 22 2024).
Popular contacts in Medical Equipment
News
Press releases by Illumina
- Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
- Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024
- Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023
- Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023
- The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk
- Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024
- Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
- Press Release 2024
- Illumina submits Form 10 to the Securities and Exchange Commission
- Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries
- View more press releases Close
Social media about Illumina
- Illumina on Wikipedia, Google News & Yahoo Finance
- Illumina on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jacob Thaysen 
